Biochemical Tumor Markers: Are New Testing Guidelines Fit for Purpose? - Top-Institutions - MDSpire

Biochemical Tumor Markers: Are New Testing Guidelines Fit for Purpose?

CLSI guidance achieves technical excellence but has some questionable omissions, says Mustafa Barbhuiya

  • By

  • Mustafa Barbhuiya

  • March 18, 2026

  • 4 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    Mayo Clinic
    Mayo Clinic

    Rochester, MN

    Key Differentiators

    • Clinical Chemistry
    • Oncology
    • Laboratory Medicine

  • #2

    Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer Center

    New York, NY

    Key Differentiators

    • Oncology
    • Clinical Chemistry
    • Hematology

  • #3

    Johns Hopkins University School of Medicine
    Johns Hopkins University School of Medicine

    Baltimore, MD

    Key Differentiators

    • Clinical Pathology
    • Oncology
    • Laboratory Medicine

  • #4

    University of California, San Francisco (UCSF) Medical Center
    University of California, San Francisco (UCSF) Medical Center

    San Francisco, CA

    Key Differentiators

    • Laboratory Medicine
    • Oncology
    • Clinical Chemistry

  • #5

    Cleveland Clinic
    Cleveland Clinic

    Cleveland, OH

    Key Differentiators

    • Clinical Chemistry
    • Oncology
    • Laboratory Medicine

Original Source(s)

Biochemical Tumor Markers: Are New Testing Guidelines Fit for Purpose?

  • by Mustafa Barbhuiya

  • March 18, 2026

Related Content

Case Report: [225Ac]Ac-PSMA-617 therapy in a patient with metastatic castration-resistant prostate cancer (mCRPC) and intracranial meningioma

Outcomes of critically ill pediatric patients after haploidentical stem cell transplantation

Diffuse large B-cell lymphoma presenting as a scalp tumor with skull destruction and neurological symptoms: a case report